H.R.6062 - To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.116th Congress (2019-2020)
|Sponsor:||Rep. Schneider, Bradley Scott [D-IL-10] (Introduced 03/03/2020)|
|Committees:||House - Energy and Commerce|
|Latest Action:||03/04/2020 Sponsor introductory remarks on measure. (CR H1476) (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.6062 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (03/03/2020)
This bill expands existing requirements relating to supply shortages of life-saving drugs to also apply to life-saving medical devices.
Generally, a manufacturer must (1) notify the Food and Drug Administration (FDA) of supply interruptions in certain circumstances, (2) provide for the expedited review of a new device that may mitigate the shortage, and (3) allow the FDA to authorize the importation of the device for emergency medical care.